WOCKHARDT
Back to Income Statement
|
WOCKHARDT Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹3,012 Cr | ₹2,798 Cr | ₹2,651 Cr | ₹3,230 Cr | ₹2,708 Cr |
What is the latest Revenue of WOCKHARDT ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹3,012 Cr |
| Mar2025 | ₹2,798 Cr |
| Mar2024 | ₹2,651 Cr |
| Mar2023 | ₹3,230 Cr |
| Mar2022 | ₹2,708 Cr |
How is Revenue of WOCKHARDT Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹3,012 Cr | 7.65 | |
| Mar2025 | ₹2,798 Cr | 5.55 | |
| Mar2024 | ₹2,651 Cr | -17.93 | |
| Mar2023 | ₹3,230 Cr | 19.28 | |
| Mar2022 | ₹2,708 Cr | - | |
Compare Revenue of peers of WOCKHARDT
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| WOCKHARDT | ₹33,527.0 Cr | -7.2% | 6.8% | 45.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹440,278.0 Cr | -2.5% | -4.7% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹243,966.0 Cr | -4% | 8.1% | 55.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,478.0 Cr | -2.3% | 0.2% | 36.6% | Stock Analytics | |
| CIPLA | ₹109,950.0 Cr | -1.7% | -6.1% | -12% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹95,967.4 Cr | -0.2% | -4.4% | -10.2% | Stock Analytics | |
WOCKHARDT Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| WOCKHARDT | -7.2% |
6.8% |
45.7% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses